
thank you for visiting seeking biotech alpha
感谢您访问寻求生物技术 寻求 α
grazie per la visita alla ricerca di biotech alpha
thank you for visiting seeking biotech alpha
感谢您访问寻求生物技术 寻求 α
grazie per la visita alla ricerca di biotech alpha
Mar. 14, 2021 3:08 PM ET AZN, BNTX, JNJ, LLY, MRK, MRNA, NVAX, PFE, VIR
https://seekingalpha.com/instablog/5205071-danwatson888/5566982-biotechope-new-day
Feb. 8, 2021 7:38 AM ET
|About: AbbVie Inc. (ABBV), ABMD, AGN, AMGN, AMRN, BGNE, BIIB, BMY, CELG, GILD, IMMU, JNJ, KPTI, REGN, SGEN, VIR, ISRG
Summary
On January 29, 2021 I increased my positions in (JNJ) on a down day for (JNJ)??, when they released their findings on their vaccine.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV)(AZN) since September 2020.
Our markets look foolish and more like gambling/gaming then investing.
For more a comprehensive perspective on Covid-19 I now view other information sources from around the world.
“OK Boomer” or even “Boomer” – does not mean anything positive now.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5552661-take-me-on-ride-biotecwar
Jan. 20, 2021 7:10 PM ET| About: AbbVie Inc. (ABBV), AZN, BGNE, BMRN, BMY, BNTX, JNJ, LLY, MRK, MRNA, PFE, RHHBY, SGEN
Summary
After a storm sometimes skies become clearer.
Many companies are now considering or have already concluded that they will no longer fund politicos, either all of them, or some of them.
“The World’s Most Loathed Industry Gave Us a Vaccine in Record Time”.
I have been adding long positions in (MRK) (GILD) (AMGN) (JNJ) (ABBV) (AZN) since September 2020 to the "SeekingBiotechAlpha" portfolio.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5545353-revival-s-in-air-biotecwars
Maps, charts, and data provided by the CDC, updated daily by 8 pm ET
In the U.S., 212 million doses have been administered Updated: April 19, 2021, 5:22 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 209 million doses have been administered Updated: April 18, 2021, 3:56 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 198 million doses have been administered Updated: April 15, 2021, 4:07 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 195 million doses have been administered Updated: April 14, 2021, 4:44 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 192 million doses have been administered; rollout goes global Updated: April 14, 2021, 8:48 AM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 192 million doses have been administered; rollout goes global Updated: April 13, 2021, 2:25 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 187 million doses have been administered; rollout goes global Updated: April 11, 2021, 8:27 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 183 million doses have been administered; rollout goes global Updated: April 10, 2021, 9:16 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 179 million doses have been administered; rollout goes global Updated: April 9, 2021, 5:01 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 171 million doses have been administered; rollout goes global Updated: April 7, 2021, 4:49 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 169 million doses have been administered; rollout goes global Updated: April 6, 2021, 9:28 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 167 million doses have been administered; rollout goes global Updated: April 5, 2021, 4:55 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 167 million doses have been administered; rollout goes global Updated: April 5, 2021, 2:38 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 165 million doses have been administered; rollout goes global Updated: April 4, 2021, 3:16 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 162 million doses have been administered; rollout goes global Updated: April 3, 2021, 3:55 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 158 million doses have been administered; rollout goes global Updated: April 2, 2021, 4:25 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 154 million doses have been administered; rollout goes global Updated: April 1, 2021, 5:20 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 150 million doses have been administered; rollout goes global Updated: March 31, 2021, 9:32 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 150 million doses have been administered; rollout goes global Updated: March 31, 2021, 1:50 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 148 million doses have been administered; rollout goes global Updated: March 30, 2021, 7:49 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 146 million doses have been administered; rollout goes global Updated: March 29, 2021, 5:11 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 143 million doses have been administered; rollout goes global Updated: March 28, 2021, 3:05 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 143 million doses have been administered; rollout goes global Updated: March 28, 2021, 3:05 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 140 million doses have been administered; rollout goes global Updated: March 27, 2021, 8:06 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 140 million doses have been administered; rollout goes global Updated: March 27, 2021, 1:50 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 137 million doses have been administered; rollout goes global Updated: March 26, 2021, 4:31 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 133 million doses have been administered; rollout goes global Updated: March 25, 2021, 5:16 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 130 million doses have been administered; rollout goes global Updated: March 24, 2021, 4:26 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 130 million doses have been administered; rollout goes global Updated: March 24, 2021, 1:57 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 128 million doses have been administered; rollout goes global Updated: March 23, 2021, 4:41 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 127 million doses have been administered; rollout goes global Updated: March 22, 2021, 5:02 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 127 million doses have been administered; rollout goes global Updated: March 22, 2021, 12:58 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 124 million doses have been administered; rollout goes global Updated: March 21, 2021, 8:38 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 116 million doses have been administered; rollout goes global Updated: March 18, 2021, 6:24 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 113 million doses have been administered; rollout goes global Updated: March 17, 2021, 4:39 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 111 million doses have been administered; rollout goes global Updated: March 16, 2021, 4:48 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 109 million doses have been administered; rollout goes global Updated: March 15, 2021, 4:32 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 109 million doses have been administered; rollout goes global Updated: March 15, 2021, 2:10 PM EDT https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 107 million doses have been administered; rollout goes global Updated: March 14, 2021, 4:25 PM EDT
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 106 million doses have been administered; rollout goes global Updated: March 13, 2021, 6:07 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 101 million doses have been administered; rollout goes global Updated: March 12, 2021, 4:09 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 95.7 million doses have been administered; rollout goes global Updated: March 10, 2021, 5:27 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 93.7 million doses have been administered; rollout goes global Updated: March 9, 2021, 4:44 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 93.7 million doses have been administered; rollout goes global Updated: March 9, 2021, 1:43 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 92.1 million doses have been administered; rollout goes global Updated: March 8, 2021, 4:09 PM EST https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 90.4 million doses have been administered; rollout goes global Updated: March 7, 2021, 4:08 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 87.9 million doses have been administered; rollout goes global Updated: March 6, 2021, 4:28 PM EST https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 82.6 million doses have been administered; rollout goes global Updated: March 4, 2021, 5:17 PM EST https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 82.6 million doses have been administered; rollout goes global Updated: March 4, 2021, 1:48 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 80.5 million doses have been administered; rollout goes global Updated: March 3, 2021, 5:19 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 78.6 million doses have been administered; rollout goes global Updated: March 2, 2021, 6:13 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 76.9 million doses have been administered; rollout goes global Updated: March 1, 2021, 4:53 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 75.2 million doses have been administered; rollout goes global Updated: February 28, 2021, 3:44 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=coronavirus
In the U.S., 72.8 million doses have been administered; rollout goes global Updated: February 27, 2021, 4:10 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 70.5 million doses have been administered; rollout goes global Updated: February 26, 2021, 4:56 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 68.3 million doses have been administered; rollout goes global Updated: February 25, 2021, 6:08 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 66.5 million doses have been administered; rollout goes global Updated: February 24, 2021, 6:56 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 65 million doses have been administered; rollout goes global Updated: February 23, 2021, 6:12 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 64.2 million doses have been administered; rollout goes global Updated: February 22, 2021, 6:27 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 64.2 million doses have been administered; rollout goes global Updated: February 22, 2021, 1:37 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 63.1 million doses have been administered; rollout goes global Updated: February 21, 2021, 5:34 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 61.3 million doses have been administered; rollout goes global Updated: February 20, 2021, 8:49 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 60.5 million doses have been administered; rollout goes global Updated: February 19, 2021, 8:12 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 59.1 million doses have been administered; rollout goes global Updated: February 18, 2021, 6:43 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 57.4 million doses have been administered; rollout goes global Updated: February 17, 2021, 7:12 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 56.1 million doses have been administered; rollout goes global Updated: February 16, 2021, 7:01 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
By Jordan Fabian and Josh Wingrove February 16, 2021, 9:30 AM PST Updated on February 16, 2021, 10:11 AM PST
U.S. Vaccine Supply Increasing to 13.5 Million Doses a Week
In the U.S., 54.6 million doses have been administered; rollout goes global Updated: February 15, 2021, 3:19 PM PST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
Dan Watson gets a 2nd jab of the Pfizer (PFE) Covid-19 vaccine on February 15, 2021
at Rowan College of South Jersey (RCSJ) Sewell NJ (Gloucester Main Campus) Mega Site
In the U.S., 44.4 million doses have been administered; rollout goes global Updated: February 9, 2021, 5:26 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 43.1 million doses have been administered; rollout goes global Updated: February 8, 2021, 6:07 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 42 million doses have been administered; rollout goes globalUpdated: February 7, 2021, 4:18 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 40.5 million doses have been administered; rollout goes global Updated: February 6, 2021, 5:01 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 38.5 million doses have been administered; rollout goes global Updated: February 5, 2021, 5:55 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 36.7 million doses have been administered; rollout goes globalUpdated: February 4, 2021, 7:16 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 35 million doses have been administered; rollout goes global Updated: February 3, 2021, 6:36 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 33.7 million doses have been administered; rollout goes global Updated: February 2, 2021, 6:06 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
In the U.S., 32.8 million doses have been administered: Covid-19 Vaccine Tracker Updated: February 1, 2021, 6:33 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 31.8 million doses; vaccine campaign goes global Updated: January 31, 2021, 8:05 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 31.8 million doses; vaccine campaign goes globalUpdated: January 31, 2021, 5:37 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 30.5 million doses; vaccine campaign goes global Updated: January 30, 2021, 5:12 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 28.9 million doses; vaccine campaign goes global Updated: January 29, 2021, 5:13 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 27.3 million doses; vaccine campaign goes global Updated: January 28, 2021, 8:03 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 25.6 million doses; vaccine campaign goes global Updated: January 27, 2021, 5:05 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 24.5 million doses; vaccine campaign goes globalUpdated: January 27, 2021, 12:35 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 23.5 million doses; vaccine campaign goes global Updated: January 25, 2021, 6:49 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 23.1 million doses; vaccine campaign goes globalUpdated: January 25, 2021, 6:12 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 22.4 million doses; vaccine campaign goes globa lUpdated: January 24, 2021, 6:01 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
Dan Watson gets a 1st jab of the Pfizer (PFE) Covid-19 vaccine on January 24, 2021
at Rowan College of South Jersey (RCSJ) Sewell NJ (Gloucester Main Campus) Mega Site
The U.S. has administered 21.1 million doses; vaccination campaign goes global Updated: January 23, 2021, 5:54 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 19.8 million doses; Europe’s rollout begins Updated: January 22, 2021, 5:55 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 18.4 million doses; Europe’s rollout begins Updated: January 21, 2021, 6:42 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 17.2 million doses; Europe’s rollout begins Updated: January 20, 2021, 6:34 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 16.3 million doses; Europe’s rollout begins Updated: January 20, 2021, 9:16 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 15.6 million doses; Europe’s rollout begins Updated: January 19, 2021, 6:05 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 14.7 million doses; Europe’s rollout begins Updated: January 18, 2021, 5:13 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 14.3 million doses; Europe’s rollout begins Updated: January 17, 2021, 5:31 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 13.7 million doses; Europe’s rollout begins Updated: January 16, 2021, 7:08 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 13 million doses; Europe’s rollout begins Updated: January 16, 2021, 1:47 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 11.9 million doses; Europe’s rollout begins Updated: January 14, 2021, 10:13 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 11.3 million doses; Europe’s rollout begins Updated: January 14, 2021, 7:29 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 10.8 million doses; Europe’s rollout beginsUpdated: January 13, 2021, 5:41 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 9.94 million doses; Europe’s rollout begins Updated: January 12, 2021, 5:29 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 9.27 million doses; Europe’s rollout begins Updated: January 11, 2021, 6:49 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 8.07 million doses; Europe’s rollout begins Updated: January 11, 2021, 11:13 AM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 8.02 million doses; Europe’s rollout begins Updated: January 10, 2021, 5:07 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 7.73 million doses; Europe’s rollout begins Updated: January 9, 2021, 8:30 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 7.05 million doses; Europe’s rollout begins Updated: January 8, 2021, 5:23 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 6.25 million doses; Europe’s rollout begins Updated: January 7, 2021, 6:56 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 5.48 million doses; Europe’s rollout begins Updated: January 6, 2021, 8:27 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 5.05 million doses; Europe’s rollout begins Updated: January 5, 2021, 6:31 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 4.66 million doses; Europe’s rollout begins Updated: January 4, 2021, 4:32 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 4.33 million doses; Europe’s rollout begins Updated: January 3, 2021, 8:04 PM EST
The U.S. has administered 4.28 million doses; Europe’s rollout begins Updated: January 2, 2021, 4:59 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 3.49 million doses; Europe’s rollout begins Updated: January 1, 2021, 5:21 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 3.17 million doses; Europe’s rollout begins Updated: December 31, 2020, 5:29 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 3.05 million doses—the most of any country so far Updated: December 30, 2020, 11:16 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 1.94 million doses, according to the CDC Updated: December 26, 2020, 3:52 PM EST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
The U.S. has administered 1.23 million doses, according to Bloomberg’s count Updated: December 24, 2020, 1:42 PM EST
What You Need to Know About Getting Tested for Coronavirus Long lines, slow results and inconsistent advice have left many of us confused about when and how to get tested. We talked to the experts to answer your questions.
By Tara Parker-Pope and Katherine J. Wu Dec. 9, 2020
https://www.nytimes.com/2020/12/09/well/live/covid-coronavirus-testing.html
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
By Washington Post staff
Johns Hopkins experts in global public health, infectious disease, and emergency preparedness have been at the forefront of the international response to COVID-19.
This website is a resource to help advance the understanding of the virus, inform the public, and brief policymakers in order to guide a response, improve care, and save lives.
This Project is supported by Bloomberg Philanthropies and the Stavros Niarchos Foundation (SNF).
By Marisa Iati
QuickTake
By John Lauerman December 31, 2020, 12:01 AM EST
NEW JERSEY
COVID-19 Information Hub
Call (General COVID-19 Questions): 2-1-1 (24/7)
Call (Medical COVID-19 Questions): 1-800-962-1253 (24/7)
Call (Vaccine Appointment Support): 1-855-568-0545 (8a-8p)
Text NJCOVID to 898-211 to receive alerts
Download COVID Alert NJ app here
•Jan 4, 2021
South China Morning Post South China Morning Post
https://www.nytimes.com/live/2021/01/07/world/covid-19-coronavirus
By Antonia Noori Farzan, Erin Cunningham, Marisa Iati, Miriam Berger, Brittany Shammas and Taylor Telford Jan. 5, 2021 at 1:55 p.m. EST
https://www.washingtonpost.com/nation/2021/01/05/coronavirus-covid-live-updates-us/
Prognosis
One Person in 50 in England Now Has Covid, Government Says
N.Y. Seeking More Vaccine Supply Ahead of Distribution Increase
Covid Spike in U.S. South Dwarfs All Earlier Regional Hot Spots
More Than 13 Million Shots Given: Covid-19 Vaccine Tracker
•Jan 5, 2021
ABC News
Countries are falling short of the inoculation targets set by leaders. There are more than twice as many Covid-19 patients in California hospitals now as there were a month ago.
Merkel announces an extension of the lockdown in Germany.
https://www.nytimes.com/live/2021/01/05/world/covid-19-coronavirus
LIVE UPDATES
UPDATED TUE, JAN 5 20211:19 PM EST
CNBC.com staff
https://www.cnbc.com/2021/01/05/covid-live-updates.html
At least one thing went right in 2020: Pharmaceutical companies came through. Thank you, science.
By Drew Armstrong
Prognosis
Tuesday, December 29, 2020 - 01:11pm
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005380/en/
Monday, December 21, 2020 - 02:09pm
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine earlier today. The EC granted this CMA in the interest of public health to help address the COVID-19 pandemic. The CMA is valid in all 27 member states of the European Union (EU).
Wednesday, December 23, 2020 - 07:00am
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 Vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July 2020, the U.S. government will pay $1.95 billion for the additional 100 million doses.
PUBLISHED MON, JAN 4 20213:01 AM ESTUPDATED MON, JAN 4 20217:22 AM ESTHolly Ellyatt@HOLLYELLYAT
Regulator could approve the jab by midweek, according to local media.
BY LAURENS CERULUS December 27, 2020 11:11 am
PUBLISHED WED, DEC 30 20201:57 AM ESTUPDATED WED, DEC 30 20207:34 AM ESTMatt Clinch@MATTCLINCH81Holly Ellyatt@HOLLYELLYATTKEY POINTS
PUBLISHED25 September 2020
JANUARY 1, 20215:38 PM
By Reuters Staff
South Africa to import 1.5M doses of the AstraZeneca vaccine
Today, 7:02 AM
December 23, 2020 6:45 am EST KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK),
Agencies Published: 1:15pm, 1 Jan, 2021
December 19, 2020 at 9:44 PM ESTPDF Version
Recommendation follows yesterday’s U.S. FDA authorization for emergency use of the Moderna COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 19, 2020-- Moderna, Inc., (Nasdaq: MRNA
December 23, 2020 at 4:10 PM ESTPDF Version
The Moderna COVID-19 Vaccine expresses the full-length Spike protein of the SARS-COV-2 virus, allowing for the generation of neutralizing antibody responses to multiple domains of the protein. The full-length Spike protein is 1,273 amino acids long, so while recent variants involve multiple mutations, for instance up to 8 amino acid changes in the spike protein of the B1.1.7 strain, these represent less than a 1% difference from the spike protein encoded by Moderna’s vaccine.
December 23, 2020 at 11:20 AM EST PDF Version
Authorization under Health Canada's Interim Order
Canadian government has secured 40 million doses
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order.
December 18, 2020
Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico
December 18, 2020 Tags | Product
Study will provide real-world data and insight on various infusion setting experiences Plan to study bamlanivimab in a diverse group of participants, including Native American communities INDIANAPOLIS , Dec. 18, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to begin
December 11, 2020
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine
December 11, 2020 Tags | Product
INDIANAPOLIS , Dec. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy
NDIANAPOLIS, Dec. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The Phase 3 study included 1,033 patients from 67 trial sites in eight countries. These results support the emergency use authorization (EUA) issued by the U.S. Food and Drug Administration (FDA) on Nov. 19 for baricitinib in combination with remdesivir in hospitalized patients with COVID-19 requiring supplemental oxygen.
Dec 31, 2020 02:58 PM WORLD
Veklury® (remdesivir) is a nucleotide analog invented by Gilead, building on more than a decade of the company’s antiviral research. Veklury has broad-spectrum antiviral activity both in vitro and in vivo in animal models against multiple emerging viral pathogens, including Ebola, SARS, Marburg, MERS and SARS-CoV-2, the virus that causes COVID-19.
https://www.gilead.com/purpose/advancing-global-health/covid-19/about-veklury
December 29, 2020 at 4:30 PM EST
TARRYTOWN, N.Y., Dec. 29, 2020 /PRNewswire/ --
Phase 3 program in hospitalized patients to continue based on passing futility analysis on ability to reduce incidence of death or mechanical ventilation
As in earlier outpatient trial, immune status when patients entered the trial was a strong predictor of viral load and clinical outcomes
First antibody therapy to demonstrate anti-viral effect in patients hospitalized with COVID-19
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
December 17, 2020 at 5:00 PM EST Back
TARRYTOWN, N.Y., Dec. 17, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19.
Phila Siu , Lilian Cheng and Elizabeth Cheung
Zhuang Pinghui in Beijing and Simone McCarthy Published: 12:00pm, 31 Dec, 2020
China grants conditional market approval for its first homemade COVID-19 vaccine
By Leng Shumei, Hu Yuwei and Zhang Hui Published: Dec 31, 2020 10:11 AM Updated: Dec 31, 2020 04:11 PM
Associated Press Published: 2:44am, 25 Dec, 2020
By Rachel Schraer
Health reporter
Ten people have been given antibodies as a form of emergency protection after being exposed to coronavirus, in the first trial of its kind.
https://www.bbc.com/news/health-55438758
DECEMBER 23, 20203:23 PMUPDATED 17 HOURS AGO
By Brendan Pierson (Reuters) -
•Dec 23, 2020
South China Morning Post South China Morning Post
By Marisa Iati Jan. 1, 2021 at 1:49 p.m. EST
https://www.washingtonpost.com/nation/2021/01/01/coronavirus-covid-updates/
#ABCNews #COVID19 #NewCoronavirusVariant
•Dec 24, 2020
ABC News ABC News
Prognosis
Bloomberg News December 30, 2020, 6:15 PM EST Updated on December 31, 2020, 7:54 AM EST
Jan 02, 2021 07:34 PM
By Lu Zhenhua
•Jan 4, 2021
CNBC Television Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, says he is conducting research to neutralize a new South African Covid-19 variant. He says the U.S. needs to identify mutant strains faster to tackle this problem.
States in the West and South have the highest shares of residents hospitalized as Los Angeles hospitals turned away ambulances. By Fenit Nirappil and William Wan
•Dec 30, 2020
Bloomberg Markets and Finance Bloomberg Markets and Finance
William Langley Published: 11:30pm, 30 Dec, 2020
Keegan Elmer in Beijing Published: 8:18pm, 19 Mar, 2020
https://www.bbc.com/news/world-asia-china-51403795
BACKCHANNEL05.01.2020 07:00 AM
The dawn of a pandemic—as seen through the news and social media posts that vanished from China’s internet.
Cissy Zhou Published: 12:05am, 7 Feb, 2020
Guo Rui in Guangzhou and Jane Cai
Published: 11:00am, 15 Feb, 2020
BY SOPHIE LEWIS
FEBRUARY 6, 2020 / 4:09 PM / CBS NEWS
The announcement comes weeks after President Trump limited the number of Chinese citizens who can work in the United States for five state-run Chinese news organizations.
SHAWN YUAN BACKCHANNEL05.01.2020 07:00 AM
The dawn of a pandemic—as seen through the news and social media posts that vanished from China’s internet.
That day, a Wuhan doctor named Li Wenliang—a whistleblower who had raised alarms about the virus in late December, only to be reprimanded for “spreading rumors”—died of Covid-19.
Within hours, his death sparked a spectacular outpouring of collective grief on Chinese social media—an outpouring that was promptly snuffed out, post by post, minute by minute. With that, grief turned to wrath, and posts demanding freedom of speech erupted across China’s social media platforms as the night went on.
Dec. 8, 2020 8:08 PM ET| About: AbbVie Inc. (ABBV), AMGN, AZN, BGNE, GILD, GSK, JNJ, MRK, PFE
Summary
The unfortunate truth is the biotech-WAR$ are never-ending.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV) since September.
The worldwide response to this virus has been a colossal failure. America's response to this virus has been horrific.
hyperinflation is already here.
https://seekingalpha.com/instablog/5205071-danwatson888/5529720-biotech-war-god-turn-around
Nov. 15, 2020 7:57 AM ET| About: Amgen Inc. (AMGN), AZN, BMY, BNTX, GSK, JNJ, LLY, MRK, MRNA, NVS, PFE, RHHBY,
“When you get on a plane everyone routes for the pilot”.
Pfizer (PFE) and Lilly (LLY) remain two of my top holdings.
Unfortunately for the state of Georgia, they will be subjected to countless new political ads for those competing for the two GA Senate races that will determine which party controls.
There have been many positive news articles on successful meds directed to cancer and other ailments just within the past 3 weeks.
Oct. 24, 2020 3:08 PM ET |About: AbbVie Inc. (ABBV), AMGN, AZN, BMRN, BMY, BNTX, DXCM, EXEL, GILD, GLPG, GSK, JNJ, LLY, MDT, MRK, MRNA, PFE, SGEN
Summary
Unfortunately the Covid-19 virus is not over.
During the recent downturn I voted to increase my positions in (AMGN) (ABBV) (JNJ) (GILD) (MRK).
We all need to understand BSL-4 Labs and confirmation of the origins of the Covid-19 virus.
I remain hopeful that politicos will go after bigger fish before they target the biotech/pharma companies.
https://seekingalpha.com/instablog/5205071-danwatson888/5512633-see-victory-biotecmax
On August 1, 2020 I started the third full page of information and updates on Covid-19/SARS CoV2.
I never thought that this www.BioHazard2020.com would result in a third full page, but it does.
My first virus posting on this site was on January 11, 2020 ( https://seekingbiotechalpha.com/2020-1 ) =
https://www.scmp.com/news/hong-kong/health-environment/article/3045750/wuhan-pneumonia-hong-kong-set-develop-new-test and https://www.caixinglobal.com/2020-01-11/first-death-from-new-sars-like-virus-reported-in-central-chinas-wuhan-101503267.html
BiotecHOPE™
There are many new medicines in testing, development and clinical trials that are currently not available or recently approved to the marketplace and many are having encouraging and positive results. There are also many approved meds that are in tests involved for other ailments/conditions that might work, where these new trials will determine. BiotecHOPE™ will seek to highlight these trials/efforts many of which are from smaller/newer biotech companies and/or are being developed by/with Universities or Hospitals.
Welcome to BiotecHOPE™ and thank you for visiting www.biotechope.com.
Sep. 28, 2020 9:38 AM ET| About: Johnson & Johnson (JNJ)
Summary
And just like that the biotech-WAR$™ are back in full force.
(JNJ) is one of my top holdings and I have been adding shares during this recent downturn.
There have been many positive and encouraging biotech news events during this one month = September 2020.
Abortion is a forever and lasting evil. Abortion is total annihilation.
https://seekingalpha.com/instablog/5205071-danwatson888/5512633-see-victory-biotecmax
Dan Watson gets a 1st jab of the Pfizer (PFE) Covid-19 Vaccine on January 24, 2021 at Rowan College of South Jersey (RCSJ) Sewell NJ (Gloucester Main Campus)
Thank you to all at Pfizer (PFE) & BioNTech (BNTX) & moderna (MRNA) &
AstraZeneca (AZN) & Novavax (NVAX) & Johnson & Johnson (JNJ) –
Bless you all.
Vaccinations are underway across New Jersey.
#nanographics #visualization #biology
•Jan 18, 2021
Too Dope for Microscope
Real SARS-CoV-2 virion in 3D
This is the first time you can see real (flash-frozen) coronavirus in 3D. We used machine learning and advanced visualization algorithms to show you the most detailed view of a real SARS-CoV-2 virion, in 3D, directly from Cryo-ET data.
The Cryo-ET data were provided by Sai Li of Tsinghua University, Beijing, China.
https://nanographics.at/projects/coronavirus-3d/
Nanographics turns your ideas, concepts, and data into images, animations, or interactive visuals. We focus on both understandability and aesthetics, so that you are able to efficiently deliver the message to your audience. Besides creating visualizations for you, we also specialize in software development, where the visual output plays a crucial role.
•Jan 25, 2021
South China Morning Post South China Morning Post
https://www.youtube.com/watch?v=W87C-1JFVIQ&feature=emb_logo
Tuesday, December 29, 2020 - 01:11pm
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005380/en/
Friday, December 11, 2020 - 11:12pm
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application (BLA) with the FDA for a possible full regulatory approval in 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201211005640/en/
NEW YORK and MAINZ, GERMANY, December 23, 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July 2020, the U.S. government will pay $1.95 billion for the additional 100 million doses.
https://seekingalpha.com/symbol/PFE
https://seekingalpha.com/symbol/BNTX
Prognosis
The bloc is pursuing a deal that could double its Pfizer shot supply.
Prognosis
NEWS/ An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
Friday, January 08, 2021 - 12:00am
New York, NY and Mainz, Germany, January 8, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv and are available here.
Prognosis
Sun January 24, 2021 9:43 PM|Associated Press|About: AZN, BNTX, PFE
SYDNEY (AP) — Australia’s medical regulator has approved use of its first coronavirus vaccine, paving the way for inoculations to begin next month.
https://seekingalpha.com/pr/18162304-asia-today-australia-oks-pfizer-vaccine-to-begin-in-feb
Moderna COVID-19 Vaccine
GO TO FULL UNITED STATES SITE HERE:
For US Vaccination ProvidersFor US Vaccine Recipients
December 23, 2020 at 11:20 AM ESTPDF Version
Authorization under Health Canada's Interim Order
Canadian government has secured 40 million doses
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order.
December 19, 2020 at 9:44 PM ESTPDF Version
Recommendation follows yesterday’s U.S. FDA authorization for emergency use of the Moderna COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 19, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Moderna COVID-19 vaccine in people 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). The committee is comprised of independent health experts. 11 ACIP members voted in favor of the vaccine and 0 members voted against.
https://seekingalpha.com/symbol/MRNA
Dec. 28, 2020 11:43 PM ETModerna, Inc. (MRNA)By: Mamta Mayani, SA News Editor17 Comments
Prognosis
January 25, 2021 at 8:28 AM ESTPDF Version
Out of an abundance of caution, Moderna launches clinical program to boost immunity to emerging variants
Manuscript posted to preprint server; company to host conference call once manuscript is available
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 25, 2021-- Moderna Inc. (Nasdaq: MRNA),
Jan. 25, 2021 9:02 AM ET Moderna, Inc. (MRNA)
By: Aakash Babu, SA News Editor9 Comments
Sep. 11, 2020 7:23 PM ET|
About: AbbVie Inc. (ABBV), Includes: ABT, AMGN, AZN, BGNE, BMY, BNTX, GSK, JNJ, LLY, MDT, MRK, MRNA, NVS, PFE, RHHBY, SNY, TMO
Summary
politicos have started again to bash biotech/pharma/healthcare companies all in an effort to gain votes and yes even during a pandemic.
Meanwhile, Biotech/pharma/med-tech companies have made significant progress in non-covid-19 medicines covering many other ailments.
AbbVie is one of my top holdings and I have been adding shares during the recent September downturn.
noteworthy positive news events over the last 2 months regarding both Covid-19 and non-Covid-19 partnerships, collaborations, mergers and acquisitions are in progress.
https://seekingalpha.com/instablog/5205071-danwatson888/5496262-biotecmax-you-keep-hope-alive
Jan. 02, 2021 2:54 AM ET Pfizer Inc. (PFE) By: Dulan Lokuwithana, SA News Editor19 Comments
https://seekingalpha.com/symbol/BNTX
At least one thing went right in 2020: Pharmaceutical companies came through. Thank you, science.
PHOTOGRAPHER: IAN LORING SHIVER FOR BLOOMBERG BUSINESSWEEK; PROP STYLIST: DAVID PROBASCO
By Drew Armstrong
•Dec 27, 2020
TODAYTOD AY
Aug. 26, 2020 5:37 PM ET
|About: AstraZeneca PLC (AZN), BNTX, CYDY, GILD, GSK, MRK, NVAX, PFE, SNY
Summary
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large."
there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus.
"I know breakthrough is coming, By faith I see a miracle
My God made me a promise, And it won't stop now"
https://seekingalpha.com/instablog/5205071-danwatson888/5489657-biotechope-won-t-stop-now
Jul. 11, 2020 12:00 PM ET
|About: Amgen Inc. (AMGN), BGNE, GILD, GSK, NVAX, PFE, AZN, JNJ
Summary
some encouraging biotech news events and hopeful USA investments in vaccine development and anti-viral development.
The number of Covid-19 cases in the USA is the highest in the world and getting worse.
a temporary truce between politicos and the biopharma community.
if there is a business sector that can unite Americans, Europeans and Chinese more than any other sector it is the biotech sector.
https://seekingalpha.com/instablog/5205071-danwatson888/5471018-biotecnova-let-light-in
Mar. 14, 2021 3:08 PM ETAZN, BNTX, JNJ, LLY, MRK, MRNA, NVAX, PFE, VIR
Long Only, Deep Value, Dividend Growth Investing, Healthcare
Feb. 8, 2021 7:38 AM ET|
About: AbbVie Inc. (ABBV), ABMD, AGN, AMGN, AMRN, BGNE, BIIB, BMY, CELG, GILD, IMMU, JNJ, KPTI, REGN, SGEN, VIR, ISRG
Summary
On January 29, 2021 I increased my positions in (JNJ) on a down day for (JNJ)??, when they released their findings on their vaccine.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV)(AZN) since September 2020.
Our markets look foolish and more like gambling/gaming then investing.
For more a comprehensive perspective on Covid-19 I now view other information sources from around the world.
“OK Boomer” or even “Boomer” – does not mean anything positive now.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5552661-take-me-on-ride-biotecwars
Jan. 20, 2021 7:10 PM ET|
About: AbbVie Inc. (ABBV), AZN, BGNE, BMRN, BMY, BNTX, JNJ, LLY, MRK, MRNA, PFE, RHHBY, SGEN
Summary
After a storm sometimes skies become clearer.
Many companies are now considering or have already concluded that they will no longer fund politicos, either all of them, or some of them.
“The World’s Most Loathed Industry Gave Us a Vaccine in Record Time”.
I have been adding long positions in (MRK) (GILD) (AMGN) (JNJ) (ABBV) (AZN) since September 2020 to the SeekingBiotechAlpha portfolio.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5545353-revival-s-in-air-biotecwars
Dec. 8, 2020 8:08 PM ET|About: AbbVie Inc. (ABBV), AMGN, AZN, BGNE, GILD, GSK, JNJ, MRK, PFE
Summary
The unfortunate truth is the biotech-WAR$ are never-ending.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV) since September.
The worldwide response to this virus has been a colossal failure. America's response to this virus has been horrific.
hyperinflation is already here.
https://seekingalpha.com/instablog/5205071-danwatson888/5529720-biotech-war-god-turn-around
Nov. 15, 2020 7:57 AM ET| About: Amgen Inc. (AMGN), AZN, BMY, BNTX, GSK, JNJ, LLY, MRK, MRNA, NVS, PFE, RHHBY, SNY
Summary
“When you get on a plane everyone routes for the pilot”.
Pfizer (PFE) and Lilly (LLY) remain two of my top holdings.
Unfortunately for the state of Georgia, they will be subjected to countless new political ads for those competing for the two GA Senate races that will determine which party controls.
There have been many positive news articles on successful meds directed to cancer and other ailments just within the past 3 weeks.
Oct. 24, 2020 3:08 PM ET |About: AbbVie Inc. (ABBV), AMGN, AZN, BMRN, BMY, BNTX, DXCM, EXEL, GILD, GLPG, GSK, JNJ, LLY, MDT, MRK, MRNA, PFE, SGEN
Summary
Unfortunately the Covid-19 virus is not over.
During the recent downturn I voted to increase my positions in (AMGN) (ABBV) (JNJ) (GILD) (MRK).
We all need to understand BSL-4 Labs and confirmation of the origins of the Covid-19 virus.
I remain hopeful that politicos will go after bigger fish before they target the biotech/pharma companies.
Sep. 28, 2020 9:38 AM ET|
About: Johnson & Johnson (JNJ)
Summary
And just like that the biotech-WAR$™ are back in full force.
(JNJ) is one of my top holdings and I have been adding shares during this recent downturn.
There have been many positive and encouraging biotech news events during this one month = September 2020.
Abortion is a forever and lasting evil. Abortion is total annihilation.
Sep. 11, 2020 7:23 PM ET|About: AbbVie Inc. (ABBV), Includes: ABT, AMGN, AZN, BGNE, BMY, BNTX, GSK, JNJ, LLY, MDT, MRK, MRNA, NVS, PFE, RHHBY, SNY, TMO
Summary
politicos have started again to bash biotech/pharma/healthcare companies all in an effort to gain votes and yes even during a pandemic.
Meanwhile, Biotech/pharma/med-tech companies have made significant progress in non-covid-19 medicines covering many other ailments.
AbbVie is one of my top holdings and I have been adding shares during the recent September downturn.
noteworthy positive news events over the last 2 months regarding both Covid-19 and non-Covid-19 partnerships, collaborations, mergers and acquisitions are in progress.
The tensions burst into the open when 163 executives joined to criticize Bill de Blasio’s leadership. Others think their portrait of the city is overly bleak.
By J. David Goodman, Emma G. Fitzsimmons and Jeffery C. Mays
Sept. 12, 2020Updated 10:29 a.m. ET
https://www.nytimes.com/2020/09/12/nyregion/coronavirus-business-nyc-reopen.html
Aug. 26, 2020 5:37 PM ET|About: AstraZeneca PLC (AZN), BNTX, CYDY, GILD, GSK, MRK, NVAX, PFE, SNY
Summary
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large."
there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus.
Jul. 11, 2020 12:00 PM ET|About: Amgen Inc. (AMGN), BGNE, GILD, GSK, NVAX, PFE, AZN, JNJ
Summary
some encouraging biotech news events and hopeful USA investments in vaccine
development and anti-viral development.
The number of Covid-19 cases in the USA is the highest in the world and getting worse.
a temporary truce between politicos and the biopharma community.
if there is a business sector that can unite Americans, Europeans and Chinese more than any other sector it is the biotech sector.
Jun. 9, 2020 5:29 PM ET|About: AbbVie Inc. (ABBV), AZN, BMY, GILD, GSK, MRK, MRNA, RHHBY
Summary
We seem to have entered into what I’ll call the “404 Pandemic”.
significant positive product news on the medical biotech front during May & June 2020.
The Camden NJ waterfront and the city of Camden NJ has come a long way from where it was, but it has taken many years to achieve it’s current level.
Many segments of American cities population were already disconnected from the economic growth and success in America.
The Importance of Placemaking.
May 11, 2020 1:11 PM ET|About: Amgen Inc. (AMGN), BGNE, BMY, LLY, REGN, VIR, WXXWY
Summary
staggering and growing rift between the world’s 2 economic powerhouses.
there are some China based biotech companies that should be considered as strong investments going forward.
biotech investments are critical and important for the health of all countries.
at this point I do not think the origins of the virus matter much as the USA/China relationship could not get much worse.
May 05, 2020 5:34 AM ET
AZN, BNTX, GSK, JNJ, PFE, SNY
Apr. 23, 2020 2:02 PM ET| About: Incyte Corporation (INCY), Includes: A, ABBV, AMGN, BDX, BMY, GILD, IMMU, LH, LLY, MDT, MRK, MRNA, NVO, NVS, RHHBY, SGEN, TMO, VIR
Summary
11 states should create a new entity = Biotechnology States of America.
Covid-19 remains a riddle, wrapped in a mystery, inside an enigma.
The political storm created by the Covid-19 virus is very real.
The economic and human loses from this event will impact America and the world for a long time.
Ruxolitinib (Jakafi®) may help prevent another complication of Covid-19.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
Apr. 14, 2020 6:24 AM ET|
About: Gilead Sciences, Inc. (GILD), JNJ, PFE
Summary
there is no evidence that the novel coronavirus (2019-nCoV) now known as = COVID-19 is or was created from a biological weapons lab or any virology lab anywhere.
There is hope with one new med previously intended for another disease – Ebola.
Remdesivir (GS-5734, Nuc inhibitor).
Thankfully there are many companies that are developing vaccines for COVID-19.
The virus is “simply a piece of bad news wrapped up in protein,”.
https://seekingalpha.com/instablog/5205071-danwatson888/5433549-biohazard2020-weapon
Long Only, Deep Value, Dividend Growth Investing, Healthcare
Apr. 5, 2020 9:48 AM ET |About: Abbott Laboratories (ABT), GILD, MDT
Summary
Politico's continue to offer confusion, misinformation, and misdirection.
Hope = Remdesivir.
One of the more intriguing news events during this virus pandemic is the simultaneous crisis in the oil sector.
New Jersey governor calls for 'postmortem' of federal response to coronavirus.
Apr. 5, 2020 9:48 AM ET|About: Abbott Laboratories (ABT), GILD, MDT
https://seekingalpha.com/instablog/5205071-danwatson888/5429826-biohazard2020-not-done-yet
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
Summary
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
The virus was the pin the popped the highly leveraged and overconfident market that many were indicating/predicting needed some adjustment. But not many were forecasting a -37% “pin” reduction vs.Jan.
an antiviral drug is a virus suppressant that blocks the chemical compounds that the virus needs for replication, its goal is to reduce the number of virus counts in the body to a manageable state.
Feb. 29, 2020 12:46 PM ET
|About: AbbVie Inc. (ABBV), GILD, JNJ, MRNA, REGN, VIR, WXXWY
Summary
the news coming from China since January 11, 2020 was never positive even if the actual reported statistical data was suspect.
everyone, including everyone in China, has a right to be angry about COVID-19.
too much single source product manufacturing located in China.
politicos are now creating “Anti-Endorsements” lists that identify successful USA citizens.
Feb. 20, 2020 10:20 AM ET|About: Amarin Corporation plc (AMRN), BMY, DBX, GILD, JNJ, MRK, NVO, NVS, PFE, RHHBY, ABBV
Summary
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.
Politicos still see little to no value in biotech companies and continue to vilify them.
There continues to be much encouraging news and positive clinical tests in the biotech world, including on the coronavirus situation, for the first 2 months of 2020.
Dec. 24, 2019 6:27 AM ET
Summary
this has been the “Biotech Decade” 2010-2019.
this year has been the “Biotech Year”.
Based on the current political environment it has been a spectacular year for the healthcare sector, and for many biotech companies.
|About: AbbVie Inc. (ABBV), ABMD, ABT, AMGN, AMRN, AZN, BGNE, BIIB, BLUE, BMRN, BMY, GILD, ISRG, JNJ, LLY, MDT, MRK, NVS, PFE, REGN, RHHBY, SGEN, SRPT, VRTX
Dec. 15, 2019 4:18 PM ET|
Summary
the biotech sector is essentially avoided, at least publicly, as a recommended investment sector.
the 2020 political BiotechSTORM is coming.
I guess that If you can’t get anyone on TV to make positive comments on biotech companies then the sector must not be well liked or a good investment?
I guess the biotech/medtech successes for the past 10 years are and will remain a secret success story and a bewildering anomaly?
There has been “Nothing Else” but biotech success stories this December 2019 as there have been the entire year of 2019.
This has been the BIOTECH DECADE -2010-2019.
Dec. 15, 2019 4:18 PM ET|About: AbbVie Inc. (ABBV), ABMD, AMGN, AMRN, AZN, BIIB, BLUE, BMY, CELG, GILD, IBB,
Dec. 31, 2019 4:20 PM ET
Summary
this has been the BIOTECH Decade.
10 years of phenomenal clinical success stories in many areas and that is “All That Matters".
And this year 2019 has been a great year for the entire biotech sector.
AbbVie Inc. (ABBV), ABMD, ABT, AMGN, AMRN, AZN, BGNE, BIIB, BLUE, BMRN, BMY, GILD, ISRG, JNJ, LLY, MDT, MRK, NVS, PFE, REGN, RHHBY, SGEN, SRPT, VRTX
Summary
politicos have made a massive mistake vilifying the biotech sector.
politicos continue to see the biotech sector as easy targets in an effort to gain votes and win elections.
It is time for all biotech companies to take counteroffensive measures.
In a year that the biotech sector has been totally maligned by politicos, biotech companies will again achieve outstanding medical success as they did in 2018. I remain 100% invested in biotech and medtech companies as of 9/18/2019. And I remain long (JNJ).
Summary
candidates now see political socialism as the “morally” correct mandate,
a significant block of voters seem to want much more and expect much more from their government.
Nevertheless, and while under attack, biotech companies continue to bring successful products to market.
I am re-investing my biotech dividends back into additional shares of the following companies; (PFE), (JNJ), (LLY), (MRK), (AMGN), (BMY), (AZN), (ABBV), (MDT), (CELG), (GILD), (NVS), (OTCQX:RHHBY)
|About: Amgen Inc. (AMGN), AZN, BMY, JNJ, MRK, PFE, Includes: ABBV, LLY
Merck Foundation Launches Five-Year Initiative to Reduce Disparities in HIV Care for Vulnerable and Underserved Southeastern US Communities.
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults Leiden, The Netherlands, September 3, 2019
–.
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC).
Dec. 9, 2019 8:35 AM ET|About: AbbVie Inc. (ABBV), ALPMY, BMY, CELG, JNJ, MRK, PFE, RHHBY, SGEN
Summary
There is no impossible.
2019, has been a breakthrough year for all who need medicine.
many clinical tests involving combinations of successful medicines.
many approvals this year in China for successful medicines.
Dec. 4, 2019 2:20 PM ET|About: Alphabet Inc. (GOOGL), Includes: BMY, JNJ, MRK, PFE, RHHBY, SGEN
Summary
politicos miss the real underlying support for the companies in the biotech/drug sector = medicine that brings about positive and encouraging outcomes, medicine that brings about successful outcomes.
The biotech/medtech success stories for all of November & early December 2019 are remarkable.
But it is not just the biotech sector that is under attack, big USA tech companies remain targets.
Nov. 23, 2019 8:40 PM ET|About: Bristol-Myers Squibb Company (BMY), CELG, Includes: AMRN, JNJ, MRK, NVO, NVS, PFE, RHHBY
Summary
For me the world is upside down when success and profit and shareholders and new medicines and new medical devises and new products are vilified, this is insanity.
New Jersey is the “Biotech State”.
Unfortunately, the Biotech-War$™ continue in November 2019 and continue to expand at a high speed towards encompassing many other WAR$ against new business sectors.
But please don’t tell any Politicos about these biotech victories below they would not understand these remarkable events – just read them At Your Whisper, shhh….
“Let’s show them we are better”.
Nov. 14, 2019 9:50 PM ET|About: Amarin Corporation plc (AMRN), BMY, MRK, PFE
Summary
“POLITICAL ZOMBIES” and are now fully targeting ALPHA.
Zombies create “Irrational FEAR”, they thrive on “Irrational FEAR”
.
HOPE is a mechanism developed by the human brain to cope with contexts and situations unfavorable to survival.
HOPEFUL news events, many are even remarkable, in the Biotech and MedTech sectors in just the first 14 days of November 2019 and they WON'T STOP NOW.
Nov. 9, 2019 6:45 PM ET|About: AbbVie Inc. (ABBV), ABMD, ABT, AGN, AMGN, AMRN, AZN, BGNE, BIIB, BMRN, BMY, CELG, GILD, ILMN, ISRG, JNJ, LLY, MDT, MRK, NVO, NVS, PFE, REGN, RHHBY, SGEN, VAR, VRTX
Summary
Politicos are now simultaneously spearheading Biotech-WAR$™, Tech WARS, and now Class WARS.
The biotech/medtech sectors continue to succeed and are on track to have another banner 2019 both in product development and financial success.
Billionaire Leon Cooperman has had enough and is fighting back.
Google and Facebook and Twitter should all fight back as should every Biotech company, every Bank, every business in the America.
Oct. 14, 2019 2:38 PM ET|About: Amgen Inc. (AMGN), AZN, BMY, GILD, JNJ, LLY, MRK, PFE, RHHBY, SGEN, MDT
Summary
I see the power of many “Biotech Victory's”. every day.
promote the power of a “Biotech Victory”.
politicos have made a grave mistake vilifying the biotech sector.
Mar. 14, 2018 1:14 PM ET|About: Amgen Inc. (AMGN), AZN, BGNE, CELG, NVS, Includes: ABMD, BMY, LLY, MDT, MRK, NVO
Summary
China Bio-Tech growth is accelerating now.
China needs better healthcare in every province.
China will welcome all bio-technology partnerships.
China is on the verge of major investment changes.
https://seekingalpha.com/instablog/5205071-danwatson888/5127900-bio-tech-china-china-china
Oct. 18, 2019 12:50 PM ET|About: AbbVie Inc. (ABBV), AMGN, JNJ, LLY, MRK, VRTX, Includes: AMRN
Summary
Are successful USA based companies now the “enemy of the state”?
Cambridge, Mass. is in my view the epicenter of the biotech industry.
The attacks on all biotech companies will only benefit biotech hubs in Shanghai, China, Basel, Switzerland and Dublin, Ireland all highly supportive biotech centers.
Apr. 2, 2019 8:20 PM ET|About: AstraZeneca PLC (AZN), BMY, CELG, Includes: AMRN, JNJ, MRK, NVO, NVS, PFE, RHHBY, SNY
Summary
“TINSTAAFL” = “There is no such thing as a free lunch”.
Princeton NJ/Central Jersey – is for me the best example of a successful BioTECH Zone.
Ireland's Life Sciences sector has grown from very humble beginnings in the 1960s to reach global significance. Collaborative clusters in Pharmaceutical, Biotechnology, Medical Devices and Diagnostics have been a key.
AstraZeneca is spearheading the creation of a new life sciences park, in Wuxi, China, that aims to nurture innovation.
Cambridge, Mass, is one of the best examples of a successful BioTECH Zone.
Nov. 2, 2019 8:29 AM ET|2 comments |About: Amgen Inc. (AMGN), BGNE, BMY, GILD, PFE, SGEN, VRTX, VAR, NVO
Summary
The progress and product successes being achieved in the Biotech sector this September and October 2019 is nothing less than remarkable.remarkable Biotech/MedTech gains in September 2019 and October 2019.In the Hebrew Bible hôšîʿâ-nā is used only in verses such as "help" or "save, I pray" (Psalms 118:25).
In the Hebrew Bible hôšîʿâ-nā is used only in verses such as "help" or "save, I pray" (Psalms 118:25).
https://seekingalpha.com/instablog/5205071-danwatson888/5369912-hosanna
Feb. 20, 2020 10:20 AM ET|About: Amarin Corporation plc (AMRN), BMY, DBX, GILD, JNJ, MRK, NVO, NVS, PFE, RHHBY, ABBV
Summary
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.